{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:10:47Z","timestamp":1791925847463,"version":"4.3.4"},"reference-count":32,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"DOI":"10.1210\/jc.2011-3479","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T11:48:55Z","timestamp":1340365735000},"page":"3097-3106","source":"Crossref","is-referenced-by-count":251,"title":["Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1\u201334] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk"],"prefix":"10.1210","volume":"97","author":[{"given":"Toshitaka","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery (T.Nakam.), University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Internal Medicine 1 (T.Su.), Shimane University Faculty of Medicine, Izumo 693-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Nakano","sequence":"additional","affiliation":[{"name":"Tamana Central Hospital (T.Nakan.), Tamana 865-0064, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Sanin Rosai Hospital (H.K.), Yonago 683-8605, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Radiology (M.I.), Nagasaki University School of Medicine, Nagasaki 852-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Kawasaki Medical School (M.F.), Kurashiki 701-0192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hagino","sequence":"additional","affiliation":[{"name":"School of Health Science & Rehabilitation Division (H.H.), Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Sone","sequence":"additional","affiliation":[{"name":"Department of Radiology (T.So.), Division of Nuclear Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery (H.Y.), Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"Osaka City University (Y.N.), Osaka 558-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Fujita","sequence":"additional","affiliation":[{"name":"Katsuragi Hospital (T.F.), Kishiwada 590-0842, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Shiraki","sequence":"additional","affiliation":[{"name":"Research Institute and Practice for Involutional Diseases (M.S.), Azumino 399-8101, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114141302000_B1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcome of osteoporotic fractures.","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114141302000_B2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on bone density in men with osteoporosis.","volume":"18","author":"Orwoll","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114141302000_B3","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effects of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis.","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114141302000_B4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bone.2010.05.022","article-title":"Effects of teriparatide on bone mineral density and biochemical markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases.","volume":"47","author":"Miyauchi","year":"2010","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114141302000_B5","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","article-title":"Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.","volume":"16","author":"Dempster","year":"2001","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114141302000_B6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S8756-3282(00)00316-1","article-title":"Histomorphometric evidence for increased bone turnover and cortical thickness without increased cortical porosity after 2 years of cyclical hPTH (1\u201334) therapy in women with severe osteoporosis.","volume":"27","author":"Hodsman","year":"2000","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114141302000_B7","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","article-title":"Recombinant human parathyroid hormone (1\u201334) [teriparatide] improves both cortical and cancellous bone structure.","volume":"18","author":"Jiang","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114141302000_B8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1359\/jbmr.2003.18.3.539","article-title":"Effects of teriparatide [recombinant human parathyroid hormone (1\u201334)] on cortical bone in postmenopausal women with osteoporosis.","volume":"18","author":"Zanchetta","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114141302000_B9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s001980050151","article-title":"Effect of an intermittent weekly dose of human parathyroid hormone (1\u201334) on osteoporosis: a randomized double-masked prospective study using three dose levels.","volume":"9","author":"Fujita","year":"1999","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114141302000_B10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.5650110716","article-title":"Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis.","volume":"11","author":"Genant","year":"1996","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114141302000_B11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1532-5415.2006.00695.x","article-title":"Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective.","volume":"54","author":"Boonen","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"key\n\t\t\t\t2019041114141302000_B12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1185\/03007990902790993","article-title":"Teriparatide vertebral risk reduction determined by quantitative and qualitative radiographic assessment.","volume":"25","author":"Prevrhal","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t2019041114141302000_B13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1359\/jbmr.080506","article-title":"Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.","volume":"23","author":"Obermayer-Pietsch","year":"2008","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114141302000_B14","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1210\/jc.2007-2781","article-title":"Randomized trial of once-weekly parathyroid hormone (1\u201384) on bone mineral density and remodeling.","volume":"93","author":"Black","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114141302000_B15","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1210\/jc.2009-0154","article-title":"Effects of teriparatide retreatment in osteoporotic men and women.","volume":"94","author":"Finkelstein","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114141302000_B16","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1210\/jc.2006-0190","article-title":"Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.","volume":"91","author":"Finkelstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114141302000_B17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1056\/NEJMoa050157","article-title":"Daily and cyclic parathyroid hormone in women receiving alendronate.","volume":"353","author":"Cosman","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114141302000_B18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","article-title":"Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.","volume":"20","author":"Chen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114141302000_B19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1359\/jbmr.040117","article-title":"Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.","volume":"19","author":"Ettinger","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114141302000_B20","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1210\/jc.2002-020334","article-title":"A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1\u201334)] with alendronate in postmenopausal women with osteoporosis.","volume":"87","author":"Body","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114141302000_B21","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114141302000_B22","first-page":"3069","article-title":"Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.","volume":"85","author":"Kurland","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114141302000_B23","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI116273","article-title":"An evaluation of several biochemical markers for bone formation and resorption.","volume":"91","author":"Hodsman","year":"1993","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114141302000_B24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jc.2009-0358","article-title":"Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women.","volume":"95","author":"Cosman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114141302000_B25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1507\/endocrj.K07E-123","article-title":"Endogenous intact PTH is suppressed during teriparatide (rhPTH 1\u201334) administration in postmenopausal women with established osteoporosis.","volume":"55","author":"Anastasilakis","year":"2008","journal-title":"Endocr J"},{"key":"key\n\t\t\t\t2019041114141302000_B26","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2010-2552","article-title":"The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1.","volume":"96","author":"Gatti","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114141302000_B27","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s00198-010-1454-4","article-title":"Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1\u201334) for 18 months contribute to improvement of bone strength in ovariectomized monkeys.","volume":"22","author":"Saito","year":"2011","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114141302000_B28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3945\/ajcn.2009.29092","article-title":"Systematic review to support the development of nutrient reference intake values: challenges and solutions.","volume":"92","author":"Chung","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t2019041114141302000_B29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know.","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114141302000_B30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.2011.50","article-title":"IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims.","volume":"305","author":"Slomski","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041114141302000_B31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jbmr.328","article-title":"Why the IOM recommendations for vitamin D are deficient.","volume":"26","author":"Heaney","year":"2011","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114141302000_B32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00223-011-9499-8","article-title":"Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.","volume":"89","author":"Rizzoli","year":"2011","journal-title":"Calcif Tissue Int"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/9\/3097\/9047302\/jcem3097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T01:50:22Z","timestamp":1561859422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/9\/3097\/2536884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,1]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2011-3479","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717950087.793455526","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717950087.793455347","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,1]]}}}